Showing 1 - 3 results of 3 for search 'Steve Oghumu', query time: 0.01s Refine Results
  1. 1
    Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model

    Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model by Felipe F. Lamenza, Peyton Roth, Puja Upadhaya, Suvekshya Shrestha, Sushmitha Jagadeesha, Natalie Kazmierowicz, Natalie Horn, Hasan Pracha, Sonali Dasari, Steve Oghumu

    Published 2025-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-β, and HIF-1 signaling

    Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-β, and HIF-1 signa... by Ashley Patton, Natalie Horn, Puja Upadhaya, Patricia Sarchet, Raphael E. Pollock, Raphael E. Pollock, Steve Oghumu, Obiajulu Hans Iwenofu, Obiajulu Hans Iwenofu

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells

    Inhibition of head and neck squamous cell carcinoma by Bruton’s tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cells by Anna R. Bopp, Felipe F. Lamenza, Puja Upadhaya, Nathan M. Ryan, Natalie Kazmierowicz, Pete P. Jordanides, Arham Siddiqui, Sherefuddin H. Pracha, Peyton Roth, O. Hans Iwenofu, Steve Oghumu

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: